McKesson Re-Files Pre-Merger Notification Under the Hart-Scott-Rodino Act
December 10 2012 - 4:30PM
Business Wire
McKesson Corporation (NYSE: MCK), a leading healthcare services
and information technology company, and PSS World Medical, Inc.
(NASDAQ: PSSI), announced today that McKesson has voluntarily
withdrawn and re-filed its notification and report form filed under
the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as
amended (“HSR Act”) in connection with the proposed acquisition by
McKesson of PSS World Medical. As previously announced on October
25, 2012, McKesson and PSS World Medical have signed a definitive
agreement under which McKesson will acquire all outstanding shares
of PSS World Medical for $29.00 per share in cash.
Upon re-filing of the HSR Act notification and report forms, the
Federal Trade Commission will have an additional 30-day period in
which to determine whether to clear the proposed transaction or
issue a request for additional information and documentary
material, commonly referred to as a “second request.” McKesson and
PSS World Medical look forward to continuing to work cooperatively
and constructively with the Federal Trade Commission as it conducts
its review of the proposed transaction.
About McKesson
McKesson Corporation, currently ranked 14th on the FORTUNE 500,
is a healthcare services and information technology company
dedicated to making the business of healthcare run better. We
partner with payers, hospitals, physician offices, pharmacies,
pharmaceutical companies and others across the spectrum of care to
build healthier organizations that deliver better care to patients
in every setting. McKesson helps its customers improve their
financial, operational, and clinical performance with solutions
that include pharmaceutical and medical-surgical supply management,
healthcare information technology, and business and clinical
services. For more information, visit http://www.mckesson.com.
About PSS World Medical, Inc.
PSS World Medical, Inc. (Nasdaq:PSSI) markets and distributes
medical products and services to front-line caregivers throughout
the United States. With 4,000 team members, PSS is a leader in the
markets it serves with innovative approaches to customer service
and operational excellence. Its stated purpose is to strengthen the
clinical success and financial health of caregivers by solving
their biggest problems. The Company is focused to accelerate growth
in four markets - Physician, Laboratory, Dispensing, and Home Care
& Hospice — with products and solutions that deliver high
quality, cost effective, and convenient patient care. For more
information on PSS, visit www.pssworldmedical.com.
Photos/Multimedia Gallery Available:
http://www.businesswire.com/multimedia/home/20121210006321/en/
PSS World Medical (NASDAQ:PSSI)
Historical Stock Chart
From Oct 2024 to Nov 2024
PSS World Medical (NASDAQ:PSSI)
Historical Stock Chart
From Nov 2023 to Nov 2024